We Excel in Precision Medicine
With the help of funding from the National Institutes of Health, InvivoSciences has been able to demonstrate reconstitution of various patient-specific disease phenotypes of muscular dystrophy in engineered heart tissues. In collaboration with cardiologist Dr. Jennifer Strande at the Medical College of Wisconsin, we are mass-producing micro-engineered heart tissues using iPSCs obtained from patients’ cells.
InvivoSciences is Where Revolutionary Drug Discovery Happens
For example, we’re currently researching efforts to develop an assay system that can screen and profile drug candidates to be used for treating cardiac muscles damaged after heart attacks.
Our award-winning technology helps bring drugs to market more quickly and more accurately. InvivoSciences has won numerous awards since its launching in 2001. A full list of awards can be seen here.